atezolizumab with chemotherapy improves pfs in squamous nsclc
Published 6 years ago • 67 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
7:07
atezolizumab with chemotherapy improves pfs in squamous nsclc
-
4:02
atezolizumab with chemotherapy in first-line treatment of non-squamous nsclc
-
5:18
atezolizumab improves on single-agent chemo for nsclc not eligible for platinum-containing regimen
-
4:31
impower130: pfs and safety of adding atezolizumab to first-line nsclc therapy
-
3:44
pembrolizumab plus chemo shows prolonged os and pfs improvement vs chemo for squamous nsclc
-
2:53
first-line atezolizumab plus chemotherapy improves survival in lung cancer patients
-
8:20
impower010: atezolizumab versus best supportive care after adjuvant chemotherapy in resected nsclc
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
7:29
first-line chemotherapy with atezolizumab and bevacizumab significantly improves survival for r/...
-
7:24
atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis
-
6:16
atezolizumab added to chemotherapy prolongs progression free survival in bladder cancer
-
7:13
first-line pembrolizumab plus chemotherapy for patients with advanced squamous nsclc: 3-year fol...
-
5:05
anti–pd-l1 atezolizumab or chemotherapy as second-line therapy in patients with sclc
-
6:06
atezolizumab monotherapy vs docetaxel in 2nd and 3rd line nsclc
-
4:01
significant survival gains with atezolizumab for nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
6:20
atezolizumab for locally advanced or metastatic pd-l1-selected nsclc
-
3:11
impower150: atezolizumab, chemotherapy and bevacizumab for nsclc
-
1:08
dr. horn on the fda approval of atezolizumab plus bevacizumab and chemotherapy in nsclc